These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16258214)
1. High dose chemotherapy and stem cell support in a patient of light- and heavy-chain deposition disease with abnormal marrow cell surface antigens and no monoclonal protein. Sakakima M; Fujigaki Y; Tsuji T; Fukasawa H; Miyaji T; Naito K; Yamamoto T; Yonemura K; Ohnishi K; Hishida A Intern Med; 2005 Sep; 44(9):970-4. PubMed ID: 16258214 [TBL] [Abstract][Full Text] [Related]
2. Light- and heavy-chain deposition disease (LHCDD): difficulty in diagnosis and treatment. Suzuki K Intern Med; 2005 Sep; 44(9):915-6. PubMed ID: 16258202 [No Abstract] [Full Text] [Related]
3. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management. Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425 [TBL] [Abstract][Full Text] [Related]
4. Marked improvement by high-dose chemotherapy and autologous stem cell transplantation in a case of light chain deposition disease. Matsuzaki K; Ohsawa I; Nishitani T; Takeda Y; Inoshita H; Ishii M; Takagi M; Horikoshi S; Tomino Y J Nephrol; 2011; 24(2):246-9. PubMed ID: 21240874 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal gammopathy presenting as recurrent nephrotic syndrome: therapeutic implications. Krishnan SG; Valderrama E; Wagner JD; Mattana J; Shah HH; Appel G; Singhal PC Am J Med Sci; 2007 May; 333(5):313-6. PubMed ID: 17505177 [TBL] [Abstract][Full Text] [Related]
6. A case of monoclonal immunoglobulin light- and heavy-chain deposition disease exhibiting atypical deposition with fibrillary structures, successfully treated with chemotherapy. Nakatsuka A; Maeshima Y; Sarai A; Yanai H; Sugiyama H; Yamasaki Y; Makino H Clin Nephrol; 2005 Sep; 64(3):221-7. PubMed ID: 16175947 [TBL] [Abstract][Full Text] [Related]
7. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature]. Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442 [TBL] [Abstract][Full Text] [Related]
8. [Secondary monoclonal gammopathy after bone marrow autotransplantation as a cause of worse renal function in light chain immunoglobulin deposition disease]. Rekhtina IG; Mendeleeva LP; Stolyarevich ES; Galtseva IV; Povilaitite PE; Biryukova LS Ter Arkh; 2016; 88(6):80-83. PubMed ID: 27296267 [TBL] [Abstract][Full Text] [Related]
9. Abnormal immunoglobulin synthesis in monoclonal immunoglobulin light chain and light and heavy chain deposition disease. Buxbaum JN Amyloid; 2001 Jun; 8(2):84-93. PubMed ID: 11409038 [TBL] [Abstract][Full Text] [Related]
10. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases. Buxbaum J; Gallo G Hematol Oncol Clin North Am; 1999 Dec; 13(6):1235-48. PubMed ID: 10626147 [TBL] [Abstract][Full Text] [Related]
11. Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition. Cheng IK; Ho SK; Chan DT; Ng WK; Chan KW Am J Kidney Dis; 1996 Aug; 28(2):283-8. PubMed ID: 8768927 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease. Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545 [TBL] [Abstract][Full Text] [Related]
13. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754 [TBL] [Abstract][Full Text] [Related]
14. Resolution of mesangial light chain deposits 3 years after high-dose melphalan with autologous peripheral blood stem cell transplantation. Harada K; Akai Y; Sakan H; Yamaguchi Y; Nakatani K; Iwano M; Saito Y Clin Nephrol; 2010 Nov; 74(5):384-8. PubMed ID: 20979947 [TBL] [Abstract][Full Text] [Related]